Remdesivir: Drug used to treat Donald Trump found to have 'little to no effect' on COVID-19 survival

euronews

16 Oct 2020 0 shares 1 views

Remdesivir: Drug used to treat Donald Trump found to have 'little to no effect' on COVID-19 survival

euronews

Published 16 Oct 2020

A six-month study funded by the World Health Organisation has found experimental drugs used to treat coronavirus, remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon, have "little to no effect" on survival for patients admitted to hospital.

Full Article

Related news coverage

WHO and USFDA views on repurposed meds start a debate

Mid-Day 27 Oct 2020

The World Health Organisation (WHO) and the US Food and Drug Administration (USFDA) have taken opposite stands on repurposed..

Gilead Sciences says remdesivir plays important role for COVID-19 patients treatment
Proactive Investors 29 Oct 2020
US stocks end mixed as investors weigh coronavirus stimulus package negotiations
Proactive Investors 23 Oct 2020
US indices hit a snag as traders eye economic data and potential stimulus package agreement
Proactive Investors 23 Oct 2020
US benchmarks start mixed as traders eye economic data and potential stimulus package agreement
Proactive Investors 23 Oct 2020

More coverage

FDA Approves Antiviral Remdesivir As COVID-19 Treatment

Eurasia Review 23 Oct 2020

The US Food and Drug Administration (FDA) has approved Gilead Sciences’ expensive antiviral drug remdesivir to treat Covid-19,..

FDA Approves Remdesivir as First Therapeutic Treatment for Covid — One Week After WHO Concludes Drug Has ‘Little to No Effect’ on Patient Survival

Mediaite

22 Oct 2020

US stocks set to start with gains after latest US presidential debate fails to spook investors, stimulus package hopes remain

Proactive Investors

23 Oct 2020

US gives full approval for antiviral remdesivir drug to treat COVID-19 patients
Mid-Day 23 Oct 2020
FDA approves first COVID-19 drug: antiviral remdesivir
SeattlePI.com 22 Oct 2020

Remdesivir: Drug used to treat Donald Trump found to have 'little to no effect' on COVID-19 survival

Remdesivir: Drug used to treat Donald Trump found to have 'little to no effect' on COVID-19 survival

You might like

Related news coverage

WHO and USFDA views on repurposed meds start a debate

Advertisement

More coverage

FDA Approves Antiviral Remdesivir As COVID-19 Treatment

FDA Approves Remdesivir as First Therapeutic Treatment for Covid — One Week After WHO Concludes Drug Has ‘Little to No Effect’ on Patient Survival

US stocks set to start with gains after latest US presidential debate fails to spook investors, stimulus package hopes remain